Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Manish_Gupta
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedYear |
2000
|
| gptkbp:founder |
gptkb:Sudhir_Vaid
|
| gptkbp:headquartersLocation |
gptkb:Ahmedabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Concord Biotech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:IPODate |
2023
|
| gptkbp:ISIN |
INE07QW01010
|
| gptkbp:listedOn |
gptkb:NSE
BSE |
| gptkbp:numberOfEmployees |
over 1200
|
| gptkbp:products |
immunosuppressants
active pharmaceutical ingredients anti-infectives |
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:website |
https://www.concordbiotech.com/
|
| gptkbp:主要株主 |
gptkb:Rare_Enterprises
gptkb:Quadria_Capital |
| gptkbp:bfsParent |
gptkb:Rakesh_Jhunjhunwala
|
| gptkbp:bfsLayer |
6
|